"The impressive array of poster presentations illustrates Octapharma's strong commitment to advancing coagulation science," said Octapharma USA President Flemming Nielsen.
Octapharma USA President Flemming Nielsen Named
HOBOKEN, N.J.(June 3, 2013) - The Hemophilia Association of New Jersey (HANJ) honored Octapharma USA President Flemming Nielsen as its Humanitarian Man of the Year during its annual fundraising dinner.
Nielsen also is a member of the Management Board of Octapharma AG, the world's largest independent human protein products manufacturer, and the parent company of Octapharma USA.
"It is great honor to be selected for this award," said Nielsen
"Our partnerships with patient organizations like HANJ are very important to Octapharma USA
because we are committed to providing patients with life enhancing and saving therapies that will improve quality of life.
Patient safety is always our first priority so this is indeed a very special honor."
Nielsen joined Octapharma AG in September 2003 at its headquarters in Lachen, Switzerland, holding several financial management positions.
transferred to the U.S. in 2004 when Octapharma
entered the American marketplace.
Born and raised in Denmark, he earned a B.A. in Business from the Copenhagen Business School.
Despite significant competition in the U.S., Octapharma
has grown marketshare every year and Nielsen points to community partnership as the main reason.
"The U.S. is a key market in Octapharma's strategic growth plans," according to Nielsen
Octapharma USA President Flemming Nielsen also personally sponsors ten children through Save One Life and has been impressed by its services.
"Save One Life
acts as a humanitarian bridge to encourage individuals and families to give back to the rest of the world on a personal basis," said Nielsen